Quidel Corp (QDEL) - Financial and Strategic SWOT Analysis Review

March 2021 | 54 pages | ID: Q4164910F57EN
GlobalData

Abstracts

Quidel Corp (QDEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specimen collection devices, media and controls; and specialty products including metabolic bone markers and enzyme linked immunosorbent assays (ELISA) and reagents. The company offers its products to physician offices, hospitals, clinical and reference laboratories, universities, retail clinics, urgent care clinics, pharmacies and wellness screening centers. It distributes products through direct sales force and a network of national and regional distributors. It has presence in the US, Ireland and China, among others. Quidel is headquartered in San Diego, California, the US.

Quidel Corp Key Recent Developments

Feb 18,2021: Quidel Reports Fourth Quarter and Full Year 2020 Financial Results
Jan 07,2021: Quidel announces preliminary revenue for fourth quarter 2020; will present virtually at 39th Annual J.P. Morgan Healthcare Conference
Oct 29,2020: Quidel reports third quarter 2020 financial results
Oct 01,2020: Quidel announces preliminary revenue for third quarter 2020
Aug 24,2020: QUIDEL announces board change

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Quidel Corp - Key Facts
Quidel Corp - Key Employees
Quidel Corp - Key Employee Biographies
Quidel Corp - Major Products and Services
Quidel Corp - History
Quidel Corp - Company Statement
Quidel Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Quidel Corp - Business Description
Product Category: Cardiac Immunoassay
Overview
Performance
Product Category: Molecular Diagnostic Solutions
Overview
Performance
Product Category: Rapid Immunoassay
Overview
Performance
Product Category: Specialized Diagnostic Solutions
Overview
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: Foreign
Performance
R&D Overview
Quidel Corp - Corporate Strategy
Quidel Corp - SWOT Analysis
SWOT Analysis - Overview
Quidel Corp - Strengths
Quidel Corp - Weaknesses
Quidel Corp - Opportunities
Quidel Corp - Threats
Quidel Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Quidel Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Quidel Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Quidel Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 18, 2021: Quidel Reports Fourth Quarter and Full Year 2020 Financial Results
Jan 07, 2021: Quidel announces preliminary revenue for fourth quarter 2020; will present virtually at 39th Annual J.P. Morgan Healthcare Conference
Oct 29, 2020: Quidel reports third quarter 2020 financial results
Oct 01, 2020: Quidel announces preliminary revenue for third quarter 2020
Aug 24, 2020: QUIDEL announces board change
Jul 30, 2020: Quidel reports second quarter 2020 financial results
Jul 30, 2020: Quidel to Hold Second Fiscal Quarter 2020 Financial Results Conference Call on July 30th, 2020
Jul 06, 2020: Quidel announces preliminary revenue for second quarter 2020
Jun 11, 2020: Quidel announces Jack Schuler will retire from Quidel's Board of Directors
May 06, 2020: Quidel reports first quarter 2020 financial results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Quidel Corp, Key Facts
Quidel Corp, Key Employees
Quidel Corp, Key Employee Biographies
Quidel Corp, Major Products and Services
Quidel Corp, History
Quidel Corp, Other Locations
Quidel Corp, Subsidiaries
Quidel Corp, Key Competitors
Quidel Corp, Ratios based on current share price
Quidel Corp, Annual Ratios
Quidel Corp, Annual Ratios (Cont...1)
Quidel Corp, Annual Ratios (Cont...2)
Quidel Corp, Interim Ratios
Quidel Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Quidel Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Quidel Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Quidel Corp, Performance Chart (2016 - 2020)
Quidel Corp, Ratio Charts
Quidel Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Quidel Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021